Analyst Consensus ?
ConsensusBuy27 ratings
Bullish2592.6%
Neutral27.4%
Bearish00.0%
Cheniere Energy, Inc. · LNG · FY2026 Q3 · Calendar Q4 2026
Cheniere raises 2026 outlook as LNG volumes and contracts grow
The quarter strengthened Cheniere’s growth case through higher LNG volumes, new long-term contracts and project progress. The main counterweights are price volatility, demand elasticity and regulatory execution risk.
Reported Before market openNYSEEnergy
$61.50B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $4.28
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $5.41B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+7.1%
Event window
SPY move
-0.4%
Same window
Abnormal move
+7.5%
Stock minus SPY
Volume
2.8×
Versus trailing sessions
Subsequent drift
0.0%
Up to 20 sessions
LNGSPY benchmark
Ask FN2 about LNG FY2026 Q3
Transcript, numbers and history already loaded
What drove LNG's +7.1% move after FY2026 Q3 earnings?What changed in LNG's guidance and outlook in FY2026 Q3?Give me the bull and bear case for LNG after FY2026 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management reported record total cargoes, completed Stage 3 Train 7 ahead of schedule and secured new long-term agreements with QatarEnergy and Petrobras. It also advanced SBL and CCL expansion work.
Guidance delta
2026 adjusted EBITDA guidance was raised to $8.75–$9.25 billion and distributable cash flow guidance to $6.05–$6.55 billion.
Key takeaways
- Record total and quarterly cargo activity supported a stronger operating backdrop.
- New long-term agreements with QatarEnergy and Petrobras broadened contracted growth.
- Cash generation supported a 12% dividend increase, repurchases and $1.5 billion of capex deployment.
Management priorities
- Advance SBL expansion toward final investment decision after regulatory approvals.
- Continue construction of Corpus Christi midscale Trains 8 and 9 and pursue CCL expansion permitting.
- Target 2027 production of 56–58 mtpa while maintaining dividend growth and repurchases.
Follow LNG with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$318.94Current
$115Low
$245.97Average
$340High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Overweight | Overweight | Maintain | Oct 23, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Oct 23, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 7, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Sep 10, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 24, 2026 |
| TD Cowen | Buy | Buy | Maintain | Aug 11, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Apr 21, 2026 |
| Jefferies | Buy | Buy | Maintain | Apr 7, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 2, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Mar 24, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Mar 23, 2026 |
| B of A Securities | Buy | Buy | Maintain | Mar 20, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Mar 13, 2026 |
| UBS | Buy | Buy | Maintain | Mar 3, 2026 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jan 14, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Oct 24, 2025 |
| Mizuho | Outperform | Outperform | Maintain | Aug 29, 2025 |
| Stifel | Buy | Buy | Maintain | Apr 22, 2025 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jan 20, 2023 |
| CFRA | Hold | Hold | Maintain | May 1, 2020 |
| Bank of America | Buy | Buy | Maintain | May 8, 2018 |
| Stifel Nicolaus | Buy | Buy | Maintain | May 7, 2018 |
| Scotia Howard Weil | Sector Outperform | Sector Perform | Upgrade | Jun 14, 2016 |
| Credit Suisse | Neutral | Outperform | Downgrade | Apr 3, 2014 |
| Deutsche Bank | Buy | Buy | Maintain | Apr 2, 2014 |
| BTIG Research | Buy | Buy | Maintain | Nov 18, 2013 |
| BTIG | Buy | Buy | Maintain | Nov 18, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $318.94. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Raymond James | Analyst unavailable | $340 | $287.84 | +6.6% | Oct 19, 2026 |
| Scotiabank | Analyst unavailable | $311 | $278.59 | -2.5% | Oct 15, 2026 |
| Jefferies | Emma Schwartz | $336 | $278.18 | +5.3% | Oct 10, 2026 |
| Barclays | Analyst unavailable | $287 | $275.26 | -10.0% | Oct 7, 2026 |
| Scotiabank | Analyst unavailable | $312 | $279.48 | -2.2% | Sep 10, 2026 |
| RBC Capital | Elvira Scotto | $319 | $277.45 | +0.0% | Aug 24, 2026 |
| Argus Research | Analyst unavailable | $330 | $274.24 | +3.5% | Aug 18, 2026 |
| Morgan Stanley | Devin McDermott | $310 | $263.17 | -2.8% | Aug 7, 2026 |
| Barclays | Analyst unavailable | $279 | $265.77 | -12.5% | Aug 7, 2026 |
| Barclays | Theresa Chen | $274 | $265.03 | -14.1% | Jul 15, 2026 |
| Bernstein | Analyst unavailable | $283 | $230.86 | -11.3% | Jun 16, 2026 |
| Wolfe Research | Keith Stanley | $300 | $227.88 | -5.9% | Jun 2, 2026 |
| UBS | Analyst unavailable | $290 | $241.98 | -9.1% | May 13, 2026 |
| Scotiabank | Analyst unavailable | $288 | $263.26 | -9.7% | Apr 16, 2026 |
| UBS | Manav Gupta | $340 | $291.4 | +6.6% | Mar 26, 2026 |
| UBS | Manav Gupta | $301 | $252.64 | -5.6% | Mar 3, 2026 |
| Morgan Stanley | Devin McDermott | $236 | $223.35 | -26.0% | Feb 24, 2026 |
| Jefferies | Analyst unavailable | $251 | $207.35 | -21.3% | Jan 25, 2026 |
| Scotiabank | Brandon Bingham | $266 | $206.72 | -16.6% | Jan 16, 2026 |
| Barclays | Theresa Chen | $259 | $199.72 | -18.8% | Jan 15, 2026 |
| Wolfe Research | Analyst unavailable | $220 | $193.69 | -31.0% | Jan 14, 2026 |
| BMO Capital | Ameet Thakkar | $254 | $189.28 | -20.4% | Dec 17, 2025 |
| Goldman Sachs | John Mackay | $275 | $212 | -13.8% | Nov 3, 2025 |
| Jefferies | Analyst unavailable | $290 | $211.52 | -9.1% | Oct 30, 2025 |
| Raymond James | Analyst unavailable | $278 | $222.24 | -12.8% | Oct 24, 2025 |
| Mizuho Securities | Analyst unavailable | $273 | $242.14 | -14.4% | Aug 29, 2025 |
| Scotiabank | Brandon Bingham | $261 | $236.96 | -18.2% | Jul 15, 2025 |
| Jefferies | Sam Burwell | $288 | $236.32 | -9.7% | Jun 26, 2025 |
| Wells Fargo | Michael Blum | $267 | $236.32 | -16.3% | Jun 25, 2025 |
| UBS | Manav Gupta | $277 | $223.39 | -13.1% | Mar 18, 2025 |
| Argus Research | Analyst unavailable | $255 | $224.03 | -20.0% | Mar 18, 2025 |
| Morgan Stanley | Devin McDermott | $255 | $223.65 | -20.0% | Jan 31, 2025 |
| Mizuho Securities | Robert Mosca | $214 | $183.58 | -32.9% | Oct 29, 2024 |
| Bank of America Securities | Jean Ann Salisbury | $215 | $182.58 | -32.6% | Oct 17, 2024 |
| Barclays | Theresa Chen | $202 | $188.77 | -36.7% | Oct 15, 2024 |
| Bernstein | Bob Brackett | $217 | $167.62 | -32.0% | Jun 24, 2024 |
| Stifel Nicolaus | Benjamin Nolan | $208 | $157.54 | -34.8% | May 6, 2024 |
| Redburn Partners | Peter Low | $162 | $154.43 | -49.2% | Apr 16, 2024 |
| Mizuho Securities | Robert Mosca | $187 | $149.16 | -41.4% | Jun 22, 2023 |
| Barclays | Analyst unavailable | $192 | $153.47 | -39.8% | Jan 13, 2023 |
| Citigroup | Analyst unavailable | $190 | $143.49 | -40.4% | Jan 9, 2023 |
| Citigroup | Analyst unavailable | $205 | $163.1 | -35.7% | Dec 9, 2022 |
| Wells Fargo | Analyst unavailable | $162 | $138.4 | -49.2% | Apr 28, 2022 |
| Raymond James | Analyst unavailable | $165 | $139.26 | -48.3% | Apr 20, 2022 |
| Wolfe Research | Steve Fleishman | $151 | $129.25 | -52.7% | Feb 25, 2022 |
| Mizuho Securities | Robert Mosca | $145 | $129.25 | -54.5% | Feb 25, 2022 |
| Cowen & Co. | Jason Gabelman | $145 | $129.25 | -54.5% | Feb 25, 2022 |
| UBS | Shneur Gershuni | $145 | $104.83 | -54.5% | Jan 24, 2022 |
| Wells Fargo | Michael Blum | $123 | $100.57 | -61.4% | Dec 16, 2021 |
| J.P. Morgan | Jeremy Tonet | $133 | $104.64 | -58.3% | Oct 22, 2021 |
| Citigroup | Timm Schneider | $115 | $89.44 | -63.9% | Sep 8, 2021 |
Track every rating change on LNG the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCheniere Energy, Inc. is an energy infrastructure firm predominantly focused on liquefied natural gas (LNG) related activities within the United States. The company owns and operates two significant LNG terminals: one in Sabine Pass, located in Cameron Parish, Louisiana, and another near Corpus Christi, Texas. Beyond its terminals, Cheniere also owns the 94-mile Creole Trail pipeline, which serves to connect the Sabine Pass LNG Terminal with various interstate and intrastate pipelines. It further manages the 21.5-mile Corpus Christi pipeline, ensuring the Corpus Christi LNG terminal is linked to a diverse network of natural gas pipelines, both within and across state lines. The company also participates in the marketing of LNG and natural gas. Cheniere Energy, Inc. was established in 1983 and has its corporate headquarters in Houston, Texas.
Energy peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| AR Antero Resources Corporation | FY2026 Q3 · Calendar Q4 2026 | +22.3% | -2.2% | Antero posts record production as margin initiatives gain traction |
| EPD Enterprise Products Partners L.P. | FY2026 Q3 · Calendar Q4 2026 | — | +2.9% | Enterprise Products raises outlook as Permian growth accelerates |
| TTE TotalEnergies SE | FY2026 Q3 · Calendar Q4 2026 | — | +1.5% | TotalEnergies posts strong Q3 as refining and LNG lead growth |
| DTM DT Midstream, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +3.7% | DT Midstream raises guidance while trimming growth capital |
Latest beats and misses
Who reports nextBeat on EPS
- ARFY2026 Q3 · October 28, 2026+22.3% EPS-2.2% move
- INVHFY2026 Q3 · October 28, 2026+49.5% EPS-0.4% move
- AEMFY2026 Q3 · October 28, 2026+5.7% EPS-3.9% move
- ORLYFY2026 Q3 · October 28, 2026+4.3% EPS-2.7% move
- STRLFY2026 Q3 · October 28, 2026+22.3% EPS-0.4% move
- KGCFY2026 Q3 · October 28, 2026+8.7% EPS-6.1% move
Get the LNG recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-29T20:04:43.576357+00:00
- FN2 earnings calendar · 2026-10-29T01:23:20.584741+00:00
- Polygon adjusted daily market bars · 2026-10-29T20:30:43.489555+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-29T20:30:43.486836+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-29. For educational purposes only; not investment advice.